PATENT CLAIM ANALYSIS

Application Number: 15870233
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "009700"]

Abstract:
The present invention provides, among other things, methods and compositions for treating brain conditions. In some embodiments, the methods include administering to a subject suffering from or susceptible to a brain condition an angiotensin (1-7) peptide via either an intravenous or subcutaneous route of administration.

Claim (Index 41):
The method of  claim 40 , wherein the one or more chemical modifications comprise pegylation, acetylation, glycosylation, biotinylation, or substitution with D-amino acid or un-natural amino acid.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.2093
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13897051', '13752202', '14549096', '13757475', '14506489']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7930837711940488
- 35 USC 102 Novelty (BERT): 0.5899390761556496
- Combined Prediction Score: 0.772769301690209
- Mean Citation Score: 432.531282
- Max Citation Score: 557.58606
- Similarity Product: 384.5990815294075

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test